(22r)-22-hydroxycholesterol has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, R; Wang, Y | 1 |
1 review(s) available for (22r)-22-hydroxycholesterol and Benign Neoplasms
| Article | Year |
|---|---|
Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy.
Topics: Animals; Humans; Immunotherapy; Neoplasms; Nuclear Receptor Subfamily 1, Group F, Member 3; Small Molecule Libraries | 2018 |